![](https://www.dovepress.com/assets/img/addon/og_logo.png)
Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model
Introduction Pancreatic ductal adenocarcinoma (PDAC) has the highest mortality rate of all major cancers, with a 5-year mortality rate higher than 92%, and most patients succumb to their disease within the first year.1,2 It is the third leading cause of …